086820 — Bio Solution Co Cashflow Statement
0.000.00%
Last trade - 00:00
- KR₩122bn
- KR₩122bn
- KR₩12bn
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -698 | -1,800 | -1,685 | -8,087 | -1,249 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | -896 | -913 | 198 | 3,503 | -2,713 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -2,498 | -774 | -197 | -1,329 | 3,471 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -2,556 | -1,686 | 83.3 | -3,814 | 2,160 |
Capital Expenditures | -2,478 | -2,505 | -663 | -4,085 | -1,159 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 3,274 | 6,261 | -16,535 | -8,072 | -8,532 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Sale of Intangible Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 796 | 3,756 | -17,199 | -12,157 | -9,690 |
Financing Cash Flow Items | -1.2 | 112 | 1,299 | 1,046 | 517 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 492 | -172 | 42,642 | 416 | -442 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -1,264 | 1,883 | 25,564 | -15,513 | -7,958 |